• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲苯达唑对人体囊型包虫病的影响:剂量和疗程的作用

Effect of mebendazole on human cystic echinococcosis: the role of dosage and treatment duration.

作者信息

Vutova K, Mechkov G, Vachkov P, Petkov R, Georgiev P, Handjiev S, Ivanov A, Todorov T

机构信息

Department of Infectious Diseases, Parasitology, Epidemiology and Tropical Medicine, Faculty of Medicine, University of Medicine, Sofia, Bulgaria.

出版信息

Ann Trop Med Parasitol. 1999 Jun;93(4):357-65. doi: 10.1080/00034989958357.

DOI:10.1080/00034989958357
PMID:10656037
Abstract

Fifty-three patients with single, multiple and/or multi-organ hydatid cysts were treated with mebendazole, in varying dosages (30-70 mg/kg.day) and over varying periods (6-24 months). Treatment failure was recorded if the mebendazole had no apparent effect on cyst morphology (monitored by radiology, ultrasonography and computed tomography) or only a parasitostatic effect (characterized by mixed and transitory, hypo- and hyper-echoic changes in the lesions). Cure was indicated by a parasitocidal effect (characterized by a totally echogenic picture, increased density of the cyst contents, reduction in the size or complete disappearance of the cysts, complete detachment of the endocysts and/or calcification of the cyst wall). Treatment failure was seen in about 40% of the patients and cure in about 38%; the other 23% had an intermediate result considered as an improvement. Cure rates increased both with dosage and duration, daily dosages of 60-70, 50 and 30-40 mg/kg curing 48%, 33% and 25%, respectively. The pre-treatment condition of any cysts should be taken into consideration when determining dosage and treatment duration.

摘要

53例患有单个、多个和/或多器官包虫囊肿的患者接受了甲苯咪唑治疗,剂量(30 - 70毫克/千克·天)和疗程(6 - 24个月)各不相同。如果甲苯咪唑对囊肿形态没有明显影响(通过放射学、超声检查和计算机断层扫描监测)或只有抑菌作用(表现为病变内混合性和短暂性的低回声和高回声变化),则记录为治疗失败。杀虫作用(表现为完全呈高回声图像、囊肿内容物密度增加、囊肿大小缩小或完全消失、内囊完全分离和/或囊肿壁钙化)则表明治愈。约40%的患者治疗失败,约38%的患者治愈;另外23%的患者有被视为改善的中间结果。治愈率随剂量和疗程增加,每日剂量60 - 70毫克/千克、50毫克/千克和30 - 40毫克/千克的治愈率分别为48%、33%和25%。在确定剂量和疗程时应考虑任何囊肿的治疗前状况。

相似文献

1
Effect of mebendazole on human cystic echinococcosis: the role of dosage and treatment duration.甲苯达唑对人体囊型包虫病的影响:剂量和疗程的作用
Ann Trop Med Parasitol. 1999 Jun;93(4):357-65. doi: 10.1080/00034989958357.
2
The types and timing of the degenerative changes seen in the cysts during and after benzimidazole treatment of cystic echinococcosis.在苯并咪唑治疗囊性棘球蚴病期间及之后,囊肿中所见退行性变化的类型和时间。
Ann Trop Med Parasitol. 2005 Oct;99(7):649-59. doi: 10.1179/136485905X65125.
3
Evaluation of response to chemotherapy of human cystic echinococcosis.人体囊型包虫病化疗反应的评估
Br J Radiol. 1990 Jul;63(751):523-31. doi: 10.1259/0007-1285-63-751-523.
4
Factors influencing the response to chemotherapy in human cystic echinococcosis.影响人类囊性棘球蚴病化疗反应的因素。
Bull World Health Organ. 1992;70(3):347-58.
5
Chemotherapy of human cystic echinococcosis: comparative efficacy of mebendazole and albendazole.人类囊性棘球蚴病的化疗:甲苯达唑和阿苯达唑的疗效比较
Ann Trop Med Parasitol. 1992 Feb;86(1):59-66. doi: 10.1080/00034983.1992.11812631.
6
Abdominal hydatid disease: follow-up of mebendazole therapy by CT and ultrasonography.腹部包虫病:采用CT和超声对甲苯达唑治疗进行随访
Int Surg. 1986 Jan-Mar;71(1):22-6.
7
Experience with mebendazole in the treatment of inoperable hydatid disease in England.在英国使用甲苯咪唑治疗无法手术的包虫病的经验。
Trans R Soc Trop Med Hyg. 1982;76(4):510-8. doi: 10.1016/0035-9203(82)90151-1.
8
Long-term evaluation of patients with hydatidosis treated with benzimidazole carbamates.用苯并咪唑氨基甲酸盐治疗包虫病患者的长期评估
Clin Infect Dis. 1999 Aug;29(2):304-9. doi: 10.1086/520205.
9
High mebendazole doses in pulmonary and hepatic hydatid disease.高剂量甲苯达唑治疗肺和肝包虫病
Arch Dis Child. 1991 Apr;66(4):532-3. doi: 10.1136/adc.66.4.532.
10
An alternative mebendazole formulation for cystic echinococcosis: the treatment efficacy, pharmacokinetics and safety in mice.用于囊性棘球蚴病的另一种甲苯咪唑制剂:小鼠的治疗效果、药代动力学及安全性
Parasit Vectors. 2014 Dec 10;7:589. doi: 10.1186/s13071-014-0589-0.

引用本文的文献

1
Mebendazole, an anti-helminth drug, suppresses inflammation, oxidative stress and injury in a mouse model of ulcerative colitis.苯并咪唑类驱虫药(一种抗蠕虫药物)可抑制溃疡性结肠炎模型小鼠的炎症、氧化应激和损伤。
Sci Rep. 2022 Jun 17;12(1):10249. doi: 10.1038/s41598-022-14420-6.
2
and Efficacy of Albendazole Chitosan Microspheres with Intensity-Modulated Radiation Therapy in the Treatment of Spinal Echinococcosis.阿苯达唑壳聚糖微球联合调强放疗治疗脊柱包虫病的疗效。
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0079521. doi: 10.1128/AAC.00795-21. Epub 2021 Aug 30.
3
Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update.
阿苯达唑和甲苯达唑作为抗寄生虫和抗癌药物:更新。
Korean J Parasitol. 2021 Jun;59(3):189-225. doi: 10.3347/kjp.2021.59.3.189. Epub 2021 Jun 21.
4
Hydatid cyst of the thyroid gland with tracheal fistula: A case report and review of the literature.甲状腺包虫囊肿合并气管瘘:一例病例报告及文献复习
Exp Ther Med. 2019 Jul;18(1):573-579. doi: 10.3892/etm.2019.7620. Epub 2019 May 28.
5
Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma.苯达唑联合放疗通过抗肿瘤机制增加颅内恶性脑膜瘤啮齿动物模型的存活率。
J Neurooncol. 2018 Dec;140(3):529-538. doi: 10.1007/s11060-018-03009-7. Epub 2018 Nov 9.
6
Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.人包虫病(囊型和泡型)的药物治疗进展:化合物和治疗靶点。
PLoS Negl Trop Dis. 2018 Apr 20;12(4):e0006422. doi: 10.1371/journal.pntd.0006422. eCollection 2018 Apr.
7
Current status of diagnosis and treatment of hepatic echinococcosis.肝包虫病的诊断与治疗现状
World J Hepatol. 2016 Oct 8;8(28):1169-1181. doi: 10.4254/wjh.v8.i28.1169.
8
In vivo and in vitro efficacies of mebendazole, mefloquine and nitazoxanide against cyst echinococcosis.甲苯咪唑、甲氟喹和硝唑尼特对囊型棘球蚴病的体内和体外疗效
Parasitol Res. 2015 Jun;114(6):2213-22. doi: 10.1007/s00436-015-4412-4. Epub 2015 Mar 15.
9
An alternative mebendazole formulation for cystic echinococcosis: the treatment efficacy, pharmacokinetics and safety in mice.用于囊性棘球蚴病的另一种甲苯咪唑制剂:小鼠的治疗效果、药代动力学及安全性
Parasit Vectors. 2014 Dec 10;7:589. doi: 10.1186/s13071-014-0589-0.
10
Primary intracranial and spinal hydatidosis: a retrospective study of 21 cases.颅内和脊髓原发性包虫病:21 例回顾性研究。
Pathog Glob Health. 2013 Mar;107(2):47-51. doi: 10.1179/2047773213Y.0000000072.